October 1, 2008—The statement focuses on noninvasive risk stratification for primary prevention of sudden cardiac death and is limited to techniques for ischemic, dilated, and hypertrophic cardiomyopathies.
The statement reports the findings from a writing group convened by the American Heart Association (AHA), the American College of Cardiology Foundation (ACCF), and the Heart Rhythm Society (HRS). The statement focuses on noninvasive risk stratification for primary prevention of sudden cardiac death and is limited to techniques for ischemic, dilated, and hypertrophic cardiomyopathies. The applicability of current noninvasive risk stratification are discussed, organized according to the type of testing required to obtain the information.
Topic
- Clinical Topics
- Sudden Cardiac Arrest
Resource Type
- Clinical Documents
Related Resources

Clinical Documents
18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context
March 11, 2024

Clinical Documents
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation
November 30, 2023

Clinical Documents
2003 NASPE Training Requirements for Cardiac Implantable Electronic Devices: Selection, Implantation, and Follow-Up
July 1, 2023